MERCER GLOBAL ADVISORS INC /ADV - UTAH MED PRODS INC ownership

Quarter-by-quarter ownership
MERCER GLOBAL ADVISORS INC /ADV ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$378
-6.7%
4,398
+1.1%
0.00%
-50.0%
Q2 2023$405
-4.5%
4,350
-2.9%
0.00%0.0%
Q1 2023$424
-56.4%
4,479
-53.7%
0.00%
-60.0%
Q4 2022$973
-99.9%
9,681
-0.2%
0.01%0.0%
Q3 2022$827,000
-0.7%
9,6980.0%0.01%0.0%
Q2 2022$833,000
-4.4%
9,6980.0%0.01%0.0%
Q1 2022$871,000
-10.2%
9,6980.0%0.01%
-16.7%
Q4 2021$970,000
+9.0%
9,698
+1.1%
0.01%0.0%
Q3 2021$890,000
+9.2%
9,5880.0%0.01%0.0%
Q2 2021$815,000
-1.8%
9,5880.0%0.01%
-25.0%
Q1 2021$830,000
+270.5%
9,588
+255.0%
0.01%
+60.0%
Q1 2019$224,0002,7010.01%
Other shareholders
UTAH MED PRODS INC shareholders Q4 2023
NameSharesValueWeighting ↓
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 206,929$10,644,0002.36%
Bares Capital Management 303,667$15,621,0001.28%
Clean Yield Group 9,271$477,0000.24%
Ativo Capital Management LLC 7,072$364,0000.16%
Penobscot Investment Management Company, Inc. 7,400$381,0000.13%
Ancora Advisors LLC 15,955$821,0000.11%
Wallace Capital Management Inc. 9,488$488,0000.10%
Hillsdale Investment Management Inc. 4,400$226,0000.05%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 36,300$1,867,0000.05%
CRAWFORD INVESTMENT COUNSEL INC 19,980$1,028,0000.04%
View complete list of UTAH MED PRODS INC shareholders